T Cell News and Research

Latest T Cell News and Research

Research reveals link between proteins causing Alzheimer's disease and age-related sight loss

Research reveals link between proteins causing Alzheimer's disease and age-related sight loss

Researchers characterize antibody responses to COVID-19 mRNA-based vaccine

Researchers characterize antibody responses to COVID-19 mRNA-based vaccine

Single mRNA vaccine dose may be enough for those previously exposed to SARS-CoV-2

Single mRNA vaccine dose may be enough for those previously exposed to SARS-CoV-2

Neutralizing antibodies may be evolving to keep up with SARS-CoV-2 mutations

Neutralizing antibodies may be evolving to keep up with SARS-CoV-2 mutations

Researchers confirm new drug development route for treating multiple sclerosis, asthma

Researchers confirm new drug development route for treating multiple sclerosis, asthma

Tiny antibodies naturally generated by llamas can be effective against COVID-19

Tiny antibodies naturally generated by llamas can be effective against COVID-19

New compound can reduce overactivation without impairing the body's immunity response

New compound can reduce overactivation without impairing the body's immunity response

Novel method can improve the detection of circulating tumor cells

Novel method can improve the detection of circulating tumor cells

New SARS-CoV-2 vaccine candidate produces strong immune response, prevents SARS-CoV-2 infection

New SARS-CoV-2 vaccine candidate produces strong immune response, prevents SARS-CoV-2 infection

Study identifies key gene associated with age-related brain deterioration

Study identifies key gene associated with age-related brain deterioration

Scientists use silk from transgenic silkworm to grow skeletal muscle cells

Scientists use silk from transgenic silkworm to grow skeletal muscle cells

New study may lead to therapeutic strategies for chronic lung disease

New study may lead to therapeutic strategies for chronic lung disease

Research demonstrates multivalent nanobodies overcome SARS-CoV-2 variant mutations

Research demonstrates multivalent nanobodies overcome SARS-CoV-2 variant mutations

Injectable scaffolding materials facilitate rapid healing after spinal cord injuries

Injectable scaffolding materials facilitate rapid healing after spinal cord injuries

SARS-CoV-2 variants rapidly arise in non-human hosts, potential risk for human reinfection

SARS-CoV-2 variants rapidly arise in non-human hosts, potential risk for human reinfection

Scientists study seven human coronavirus envelope proteins using topology prediction and molecular modeling

Scientists study seven human coronavirus envelope proteins using topology prediction and molecular modeling

Study reveals novel approach to reduce the risk of thrombosis by using IgM antibodies

Study reveals novel approach to reduce the risk of thrombosis by using IgM antibodies

First complete atlas of how mutations affect the formation of amyloid plaques in Alzheimer’s disease

First complete atlas of how mutations affect the formation of amyloid plaques in Alzheimer’s disease

Super-resolution system microscopy can reveal pluripotency and differentiation of live stem cells

Super-resolution system microscopy can reveal pluripotency and differentiation of live stem cells

Phase 2 clinical trial is now open at Columbia to test gene therapy for dry macular degeneration

Phase 2 clinical trial is now open at Columbia to test gene therapy for dry macular degeneration

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.